Haemonetics Corporation (HAE) Stock Quote
Get the latest HAE - Haemonetics Corporation stock market performance data and financial news.
RealMoney.com: HAE: Biotech's Latest Orphan-Drug Race
HAE: Biotech's Latest Orphan-Drug Race, ViroPharma's deal for Lev Pharma puts the
biotech in a race with Behring for potential US market exclusivity of a ...
http://www.thestreet.com/p/newsanalysis/business-news-update/10426957.html
HAE: Biotech's Latest Orphan-Drug Race
ViroPharma's deal for Lev Pharma puts the biotech in a race with Behring for potential U.S. market exclusivity of a hereditary angiodema treatment.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10426957/1/hae-biotechs-latest-orphan-drug-race.html
Jim Cramer's Take on Haemonetics Corporation
Read Jim Cramer's take on Haemonetics Corporation (HAE) and get his latest thoughts on the company?s performance and outlook
Haemonetics Corporation (HAE) Community Sentiment
Get the latest HAE - Haemonetics Corporation together with stock market performance data and financial news.
Haemonetics Corporation (HAE) Stock Quote
Get the latest HAE - Haemonetics Corporation stock market performance data and financial news.
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
For ViroPharma, Acquisition Plan Is Paying Off
Lev Pharmaceuticals, a company ViroPharma is planning to buy, received news Friday that U.S. regulators cleared Cinryze to prevent painful attacks that occur in patients with HAE.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10442423/1/for-viropharma-acquisition-plan-is-paying-off.html
RealMoney.com: For ViroPharma, Acquisition Plan Is Paying Off
... a company ViroPharma is planning to buy, received news Friday that US regulators
cleared Cinryze to prevent painful attacks that occur in patients with HAE. ...
http://www.thestreet.com/p/newsanalysis/biotech/10442423_2.html
FDA Approves Two New Drugs: BioBuzz
Dyax and Merck/Santarus get FDA approvals. The U.S. Food and Drug Administration approved two drugs Tuesday night -- a prescription drug for a rare, genetic disorder and an over-the-counter treatment for heartburn.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10636438/1/fda-approves-two-new-drugs-biobuzz.html
Connect with TheStreet